[1] Grewal IS,Flavell RA.CD40 and CD154 in cell-mediated immunity.Annu Rev Immunol,1998,16: 111-135. [2] Foy TM,Aruffo A,Bajorath J,et al.Immune regulation by CD40 and its ligand gp39.Annu Rev Immunol,1996,14:591-617. [3] Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI:a disease activity index for lupus patients: The Committee on Prognosis Studies in SLE.Arthritis Rheum,1992,35:630-640. [4] 颜子颖,王海林译.精编分子生物学实验指南.第1版.北京:科学出版社,1998.123-126 [5] 黄培堂,俞炜源,陈添弥,等译.PCR技术实验指南.第1版.北京:科学出版社,1998 4-33. [6] Desai-Mehta A,Lu L,Ramsey-Goldman R,et al.Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.J Clin Invest,1996,97:2063-2073. [7] Koshy M,Berger D,Crow MK.Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.J Clin Invest,1996,98:826-837. [8] Vakkalanka RK,Woo C,Kirou KA,et al.Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.Arthritis Rheum,1999,42:871-881. |